Best AI Medical Diagnostic Platforms - Page 5

How Many AI Medical Diagnostic Platforms Products Does G2 Track?

Total Products under this Category: 118

Category Stats (Nov 2026)

  • Average Rating: 4.4/5 (↓0.23 vs Oct 2026) The average rating of products in this category, based on all submitted ratings
  • Top Trending Product: myExam Companion (+8.75%) - Among all products in this category, myExam Companion recorded the largest rating increase compared to last month

Last updated: November 13, 2026

How Does G2 Rank AI Medical Diagnostic Platforms Products?

Why You Can Trust G2's Software Rankings:

  • 30 Analysts and Data Experts
  • 300+ Authentic Reviews
  • 118+ Products
  • Unbiased Rankings

G2's software rankings are built on verified user reviews, rigorous moderation, and a consistent research methodology maintained by a team of analysts and data experts. Each product is measured using the same transparent criteria, with no paid placement or vendor influence. While reviews reflect real user experiences, which can be subjective, they offer valuable insight into how software performs in the hands of professionals. Together, these inputs power the G2 Score, a standardized way to compare tools within every category.

G2 Grid® for AI Medical Diagnostic Platforms

G2 Grid® for AI Medical Diagnostic Platforms plotting products by satisfaction and market presence

Highlighted products: OpenEvidence, PathAI, Viz.ai One, MR SmartSpeed, 5C Network, Deep Resolve, Qure AI, and Lunit.

Underlying data: [Grid® JSON](https://www.g2.com/categories/ai-medical-diagnostic-platforms/grids.json?focus%5B%5D=openevidence&focus%5B%5D=pathai&focus%5B%5D=viz-ai-one&focus%5B%5D=mr-smartspeed&focus%5B%5D=5c-network&focus%5B%5D=deep-resolve&focus%5B%5D=qure-ai-2022-07-05&focus%5B%5D=lunit)

Guardant Health

Guardant Health is a pioneering biotechnology company dedicated to transforming cancer care through advanced blood-based diagnostics. By analyzing circulating tumor DNA (ctDNA) in blood samples, Guardant Health's innovative tests enable early cancer detection, comprehensive genomic profiling, and monitoring of treatment responses, thereby facilitating personalized treatment strategies and improving patient outcomes. Key Features and Functionality: - Guardant360® Liquid CDx: An FDA-approved liquid biopsy test that analyzes a broad panel of genomic alterations, providing critical insights for guiding targeted therapies in advanced solid tumors. - Guardant360® Tissue: A comprehensive tissue-based genomic profiling test that complements liquid biopsy results, offering a complete genomic landscape of the tumor. - Guardant Reveal®: A blood test designed for minimal residual disease (MRD) detection and recurrence monitoring in early-stage cancers, enabling timely intervention and personalized treatment adjustments. - Shield™: A blood-based screening test for colorectal cancer, offering a non-invasive alternative to traditional methods, thereby increasing screening compliance and early detection rates. Primary Value and Solutions Provided: Guardant Health's suite of products addresses critical challenges in oncology by offering non-invasive, accurate, and timely diagnostic solutions. These tests empower healthcare providers to detect cancer at its earliest stages, tailor treatments based on the tumor's unique genomic profile, and monitor disease progression or recurrence with ease. By reducing the need for invasive procedures and enabling real-time insights into tumor dynamics, Guardant Health enhances patient care, improves clinical outcomes, and contributes to the advancement of precision oncology.

Who Is the Company Behind Guardant Health?

Hairscope AI

Hairscope AI is an advanced, AI-powered hair analysis platform tailored for hair clinics, aiming to revolutionize the diagnosis, tracking, and management of hair treatments. By leveraging artificial intelligence, Hairscope provides clinics with precise, data-driven insights into hair and scalp health, enabling more accurate and personalized treatment plans. This innovative tool enhances patient engagement by offering clear visualizations of treatment progress, thereby fostering trust and commitment to the therapeutic process. Key Features and Functionality: - AI-Powered Hair Analysis: Accurately counts hair follicles, measures hair thickness, and assesses hair density, providing detailed insights into hair health. - Rapid Diagnosis: Reduces diagnosis time by up to 90% through swift detection of common hair issues, enhancing clinic efficiency. - Progress Tracking: Offers clear, quantifiable data to monitor treatment effectiveness from the outset, building patient confidence. - Lead Generation: Integrates AI selfie analysis into clinic websites, capturing potential patients with minimal effort. - User-Friendly Platform: Provides an intuitive interface requiring no technical expertise, ensuring seamless integration into clinic workflows. Primary Value and Problem Solved: Hairscope AI addresses the critical challenge of patient attrition in hair treatments, where over 70% of patients discontinue therapy within the first two months due to perceived lack of progress. By delivering measurable, data-backed results after each session, Hairscope empowers clinics to demonstrate treatment efficacy, thereby enhancing patient retention and satisfaction. Additionally, the platform streamlines clinic operations by automating diagnostic processes and facilitating efficient patient management, ultimately leading to improved treatment outcomes and clinic growth.

Who Is the Company Behind Hairscope AI?

Healthplus.ai

Healthplus.ai enables proactive surgery care

Who Is the Company Behind Healthplus.ai?

AI can help you find the answers. G2 helps you trust them.

Connect G2 to Claude or ChatGPT for answers grounded in G2's trusted reviews, comparisons, and pricing from real user insights.

How it works
Connect G2 to ChatGPTConnect G2 to Claude

HeartSciences

HeartSciences is a medical technology company dedicated to transforming the early detection of heart disease through Artificial Intelligence-Enhanced Electrocardiography (AI-ECG) solutions. By integrating advanced AI algorithms with traditional ECG technology, HeartSciences aims to identify previously undetectable cardiovascular conditions, thereby expanding the clinical utility of ECGs and facilitating earlier diagnosis and treatment. Key Features and Functionality: - MyoVista® wavECG™ Device: A high-performance 12-lead resting ECG device that incorporates proprietary AI-ECG algorithms. It provides both conventional ECG data and advanced diagnostic information related to cardiac dysfunction in a single test. - MyoVista Insights™ AI-ECG Cloud Platform: A cloud-based platform designed to deliver AI-ECG algorithms using existing ECG devices. It covers a range of important cardiovascular conditions and integrates seamlessly with existing clinical pathways. - Extensive AI-ECG Algorithm Portfolio: HeartSciences has developed one of the world's largest commercial portfolios of AI-ECG algorithms, covering a wide range of cardiovascular conditions. Primary Value and User Benefits: HeartSciences' AI-ECG solutions address the critical challenge of early heart disease detection. Traditional ECGs often fail to detect many heart conditions, leading to delayed diagnoses and treatments. By enhancing ECGs with AI, HeartSciences enables healthcare providers to identify heart disease at earlier stages, even in asymptomatic patients. This early detection facilitates timely interventions, improves patient outcomes, and has the potential to reduce healthcare costs associated with advanced-stage treatments. Moreover, the integration of AI-ECG technology into existing clinical workflows ensures that these advanced diagnostic capabilities are accessible across various healthcare settings, from large hospital systems to mobile testing services.

Who Is the Company Behind HeartSciences?

HistoWiz

HistoWiz is a pioneering digital pathology company that streamlines histology processes to accelerate scientific research and discoveries. By automating tissue processing and digitizing specimens, HistoWiz provides researchers with rapid access to high-quality digital slides, enabling efficient analysis and collaboration. Their proprietary platform, PathologyMap™, offers a comprehensive solution for managing, viewing, and sharing histopathology data, facilitating seamless integration into research workflows. Key Features and Functionality: - Precision Histology: Expert-led tissue processing and slide generation deliver high-quality results with turnaround times as fast as three days. - Advanced Immunostaining: Offers immunohistochemistry (IHC) and immunofluorescence (IF) staining with over 400 validated antibodies for detailed protein visualization. - Slide Archiving: High-throughput scanning digitizes glass slide collections, accommodating virtually all tissue types for efficient storage and retrieval. - Pathology Consultation: Provides on-demand access to a network of over 100 board-certified pathologists for expert insights and evaluations. - Image Analysis: Delivers objective assessments and measurable results through advanced image analysis, supported by seasoned experts. - PathologyMap™ Platform: A cloud-based system that enables online viewing, annotation, sharing, and collaboration on digital slides, hosting one of the largest collections of preclinical data to support AI-driven tools and quality control measures. Primary Value and Solutions: HistoWiz addresses the critical need for rapid, reliable histology services in the research community. By automating traditional processes and providing a robust digital platform, HistoWiz significantly reduces turnaround times, allowing researchers to focus on discovery and development. The integration of expert consultations and advanced analytical tools ensures high-quality data interpretation, enhancing the accuracy and efficiency of scientific studies. Ultimately, HistoWiz empowers life science companies and researchers to bring impactful breakthroughs and therapies to market with greater speed and precision than ever before.

Who Is the Company Behind HistoWiz?

  • Seller: HistoWiz
  • Year Founded: 2012
  • HQ Location: Brooklyn, US
  • LinkedIn® Page: www.linkedin.com
    7,162 employees on LinkedIn®

idoven

Idoven is a pioneering health technology company that has developed the world's first cardiology-as-a-service platform powered by artificial intelligence (AI). This innovative platform enhances clinicians' abilities to identify, triage, and diagnose patients at scale, revolutionizing cardiac care by providing rapid and accurate detection of arrhythmias and other cardiac patterns. By integrating seamlessly with various medical devices and electronic health record systems, Idoven's solution significantly reduces the time and expense associated with electrocardiogram (ECG) interpretation, thereby improving patient outcomes and advancing precision medicine in cardiology. Key Features and Functionality: - AI-Powered ECG Analysis: Utilizes advanced machine learning models to detect 22 cardiac patterns and four intervals (P Interval, PR Interval, QT Interval, and QRS duration) with cardiologist-level accuracy. - Device Neutrality: Compatible with a wide range of ECG recording devices, including ambulatory ECG devices (holter and patch), standard diagnostic resting ECG devices (12-lead), and insertable cardiac monitors (ICM). - Seamless Integration: Offers API and non-API tools for bi-directional data exchange, ensuring interoperability with home monitoring systems and electronic health records. - Certified Medical Device: Willem™, the ECG analysis platform, is certified as a Medical Device Class IIa under the EU Medical Device Regulation (EU MDR), ensuring compliance with international standards for patient safety and data security. - Robust Data Security: Operates on a secure cloud-based infrastructure compliant with ISO standards (27001, 27017, 27018, 27701, 37001) and GDPR, safeguarding patient data privacy. Primary Value and User Solutions: Idoven addresses the critical need for efficient and accurate cardiac diagnostics by leveraging AI to augment clinical capabilities. Its platform enables rapid identification of arrhythmias and cardiac patterns, reducing the time and costs associated with traditional ECG interpretation. By integrating with existing medical devices and health record systems, Idoven facilitates scalable patient triage and diagnosis, ultimately enhancing patient care and supporting preventive screening programs. This approach empowers healthcare providers to deliver timely interventions, improving patient outcomes and advancing the field of precision medicine in cardiology.

Who Is the Company Behind idoven?

  • Seller: idoven
  • Year Founded: 2018
  • HQ Location: Madrid, ES
  • LinkedIn® Page: www.linkedin.com
    74 employees on LinkedIn®

Illuminant Surgical

Illuminant Surgical is a medical technology company dedicated to enhancing surgical procedures through advanced visualization tools. Their flagship product, Skylight™, is the first real-time anatomical projection system designed for spine surgery and interventional access. By projecting critical anatomical imaging directly onto the patient's body, Skylight™ provides surgeons with an "X-ray vision" view, allowing them to visualize internal structures without the need for traditional monitors or headsets. This innovative technology simplifies workflow, integrates seamlessly into various procedure rooms, and requires minimal training for users. Key Features and Functionality: - Real-Time Anatomical Projection: Skylight™ displays imaging directly onto the patient's skin, offering immediate visual guidance during procedures. - SkinMatch™ Patient Registration: This feature simplifies the setup process, enabling non-invasive patient registration within minutes. - Seamless Integration: Designed to fit into any procedure room, Skylight™ requires minimal training and eliminates the need for additional wearables or complex equipment. - Enhanced Surgical Precision: By providing a clear, unobstructed view of internal anatomy, Skylight™ reduces spatial uncertainty and cognitive burden, allowing surgeons to focus entirely on the procedure. Primary Value and Problem Solved: Traditional surgical navigation systems often require surgeons to shift their attention between monitors and the patient, leading to potential inefficiencies and increased cognitive load. Skylight™ addresses this challenge by projecting anatomical information directly onto the patient, creating a seamless integration of digital guidance and physical reality. This innovation enhances surgical precision, simplifies workflows, and improves patient outcomes by reducing the likelihood of complications associated with misplacement or spatial uncertainty.

Who Is the Company Behind Illuminant Surgical?

Infiuss Health

Infiuss Health is revolutionizing clinical research by introducing AI-powered solutions that streamline the design and execution of randomized controlled trials. Their flagship platform, Probe, enables researchers to simulate real patient responses before initiating studies, thereby enhancing the accuracy and efficiency of clinical trials. Key Features and Functionality: - Digital Patient Twin: Creates dynamic virtual representations of patients by integrating comprehensive health data, including medical records, genomics, imaging, lab results, and wearable device information. - AI-Powered Predictions: Utilizes advanced artificial intelligence to simulate disease progression and predict treatment outcomes, allowing for proactive healthcare interventions. - Data Integration & Interoperability: Seamlessly integrates with Electronic Health Records (EHRs), wearables, and Internet of Things (IoT) devices, ensuring real-time data synchronization and compliance with HIPAA standards. - Clinical Research Insights: Provides AI-driven tools to assist researchers in protocol design and trial planning, enhancing the quality and efficiency of clinical studies. - Predictive Analytics & Simulation: Offers advanced forecasting capabilities, including "what-if" scenario modeling and early warning systems, to support proactive patient care. - Real-Time Monitoring & Alerts: Enables continuous health tracking with automated anomaly detection and proactive intervention triggers, facilitating timely medical responses. - Patient Engagement Tools: Features interactive health dashboards and personalized recommendations to enhance patient involvement and adherence to treatment protocols. Primary Value and Solutions Provided: Infiuss Health addresses critical challenges in modern healthcare by bridging the gap between laboratory research and real-world patient outcomes. By leveraging AI and comprehensive data integration, the platform enhances research accuracy, reduces adverse events, and accelerates the discovery of effective treatments. This approach not only improves patient care but also optimizes clinical operations, leading to significant cost reductions and more efficient healthcare delivery.

Who Is the Company Behind Infiuss Health?

IR-MED

IR-MED Inc. specializes in developing non-invasive, AI-driven spectrographic analysis technology designed to assist healthcare professionals in real-time assessment of blood and tissue at the point of care. Their flagship product, PressureSafe™, is a handheld device aimed at revolutionizing the early detection of pressure injuries (PIs), which are a significant healthcare challenge, costing the U.S. healthcare system $26.8 billion annually and resulting in 60,000 deaths each year. Key Features and Functionality: - Infrared Spectroscopy: Utilizes harmless infrared reflectance spectroscopy to gather bio-information from a patient's blood and tissue non-invasively. - AI-Powered Decision Support: Employs AI algorithms to analyze the collected data, providing real-time clinical decision support to healthcare providers. - Skin Tone Agnostic: Effectively detects early-stage pressure injuries across all skin tones by analyzing biomarkers beneath the skin's surface, addressing healthcare disparities. - High Accuracy: Demonstrated over 90% accuracy in detecting pressure injuries based on interim results from multicenter studies. Primary Value and User Benefits: PressureSafe™ addresses the critical need for early detection of pressure injuries, which are often preventable yet prevalent, affecting 2.5 million people annually in the U.S. By providing a non-invasive, accurate, and skin tone agnostic solution, PressureSafe™ empowers healthcare professionals to identify and treat pressure injuries at an early stage, potentially reducing patient suffering, preventing complications, and decreasing associated healthcare costs. This innovation promotes equitable healthcare by ensuring effective assessment for individuals of all skin tones.

Who Is the Company Behind IR-MED?

Isabl

Isabl is a cutting-edge platform designed to revolutionize cancer diagnostics by providing comprehensive analysis of the entire tumor genome and transcriptome. Unlike traditional panel-based tests that examine only a fraction of the genome, Isabl's technology evaluates 100% of the cancer DNA and RNA, uncovering all cancer-associated mutations in each sample. This holistic approach enhances biomarker discovery, offering more precise diagnoses and personalized treatment options for patients across various cancer types. Key Features and Functionality: - Comprehensive Genomic Analysis: Isabl's GxT platform integrates data from the entire tumor genome and transcriptome into a single diagnostic workflow, eliminating the limitations of targeted sequencing. - Advanced Bioinformatics Applications: The platform supports assembly-aware bioinformatics applications, ensuring analyses are tailored to specific reference genomes. - User-Friendly Interfaces: Isabl offers a web application for managing operations metadata and visualizing analysis results, alongside a command-line interface and software development kit for efficient data management and processing. - Operational Automations: The system automates data import and analysis status changes, streamlining workflows and reducing manual intervention. Primary Value and Solutions Provided: Isabl addresses the limitations of existing diagnostic tests by offering a more comprehensive and accurate genomic analysis. By detecting all cancer-associated mutations, including those missed by standard assays, Isabl enables better risk stratification, informed treatment planning, and improved patient outcomes. Its integration of advanced bioinformatics tools and user-friendly interfaces simplifies the diagnostic process, making full genome testing accessible and practical for clinical use. Ultimately, Isabl empowers healthcare providers with the insights needed to deliver truly personalized cancer care.

Who Is the Company Behind Isabl?

  • Seller: Isabl
  • Year Founded: 2020
  • HQ Location: New York, US
  • LinkedIn® Page: www.linkedin.com
    525 employees on LinkedIn®

iSono Health

iSono Health develops an AI platform for accessible and personalized breast health monitoring

Who Is the Company Behind iSono Health?

KnowU

KnowU is a non-invasive, wearable continuous glucose monitor (CGM) developed by Know Labs, Inc., designed to transform diabetes management for the nearly two billion individuals worldwide living with diabetes and pre-diabetes. Utilizing Know Labs' proprietary Bio-RFID™ technology, KnowU measures blood glucose levels without the need for needles or invasive procedures, offering a pain-free and convenient alternative to traditional monitoring methods. Key Features and Functionality: - Non-Invasive Monitoring: Employs radiofrequency dielectric spectroscopy to detect and measure blood glucose levels without skin penetration. - Wearable Design: Can be attached using an adhesive or worn on the wrist or forearm with a strap, providing flexibility and comfort. - Long-Term Use: Engineered for durability, the device is rechargeable and eliminates the need for disposable components like test strips and lancets. - Mobile Integration: Connects seamlessly with a companion mobile app, enabling real-time blood glucose tracking and trend analysis over time. - Cost-Effective: Offers a more affordable solution compared to existing blood glucose monitoring options, being 3 to 5 times less expensive. Primary Value and User Benefits: KnowU addresses the common challenges associated with traditional glucose monitoring, such as pain, inconvenience, and high costs. By providing a non-invasive, continuous monitoring solution, it empowers users to manage their blood glucose levels more effectively and comfortably. The device's affordability and ease of use make it accessible to a broader population, potentially improving health outcomes and quality of life for those managing diabetes and pre-diabetes.

Who Is the Company Behind KnowU?

  • Seller: KnowU
  • Year Founded: 2003
  • HQ Location: Seattle, US
  • LinkedIn® Page: www.linkedin.com
    10 employees on LinkedIn®

MDI Health

MDI Health is an AI-driven platform revolutionizing medication management by providing personalized, scalable solutions that enhance clinical outcomes, reduce healthcare costs, and improve quality measures. By analyzing complex patient profiles—including medications, conditions, labs, and demographics—MDI Health delivers instant, evidence-based recommendations to optimize medication regimens and prevent adverse drug events. Key Features and Functionality: - Comprehensive Analysis & Patient Prioritization: Utilizes interactive population health dashboards to identify high-impact opportunities based on quality metrics and cost savings. - Personalized & Actionable Clinical Recommendations: Generates ready-to-send, evidence-based recommendations tailored to individual patient needs, enhancing safety and cost efficiency. - Optimized Provider Engagement: Delivers trusted, actionable recommendations that integrate seamlessly into electronic health records (EHRs), facilitating efficient implementation by clinicians. - Population Monitoring & Outcomes Tracking: Offers live dashboards to measure key metrics such as risk reduction, medication reduction, quality gap closure, and financial impact across various disease states and provider groups. Primary Value and User Solutions: MDI Health addresses the critical issue of medication-related problems, which contribute to 12 million hospitalizations and $528 billion in avoidable healthcare costs annually. By automating and personalizing medication management, the platform empowers payers and providers to: - Reduce Total Cost of Care: Achieve significant savings in prescription and medical expenses, with potential reductions of approximately $2,000 per member per year for high-risk patients. - Enhance Quality Metrics: Improve performance in medication-related quality measures, including STAR ratings, through targeted interventions and real-time analytics. - Increase Operational Efficiency: Expand case review capacity by up to tenfold, enabling clinical teams to manage larger patient populations effectively without additional resources. By integrating advanced AI capabilities with clinical expertise, MDI Health sets a new standard in medication management, ensuring safer, more effective, and personalized treatment plans at scale.

Who Is the Company Behind MDI Health?

Medivis

Medivis is a medical technology company specializing in augmented reality (AR) and artificial intelligence (AI) to enhance surgical navigation and medical imaging. Founded in 2016 and based in New York City, Medivis aims to revolutionize surgical procedures by transforming traditional 2D medical imaging data into interactive 3D holographic visualizations, providing surgeons with real-time, patient-specific insights. Key Features and Functionality: - SurgicalAR® Platform: An FDA-cleared system that converts complex 2D imaging, such as MRIs and CT scans, into real-time 3D holographic visualizations. This allows surgeons to overlay these images onto a patient's body during surgery, enhancing spatial understanding and precision. - Spine Navigation: Utilizes AR and AI to provide holographic navigation for both open and minimally invasive spine procedures, offering real-time, context-aware insights to improve surgical accuracy. - Cranial Navigation: Designed for procedures like external ventricular drains (EVDs), subdural evacuations, and craniotomies, this system offers real-time 3D visualization to assist in complex cranial surgeries. - AnatomyX: An educational tool that leverages AR to provide immersive anatomical learning experiences, aiding in medical education and training. Primary Value and Solutions: Medivis addresses the limitations of traditional surgical navigation by integrating AR and AI technologies, offering surgeons enhanced visualization and spatial understanding during procedures. This innovation aims to improve surgical accuracy, reduce operational risks, and enhance patient outcomes. By providing real-time, interactive 3D visualizations, Medivis empowers healthcare professionals to perform complex surgeries with greater confidence and precision.

Who Is the Company Behind Medivis?

  • Seller: Medivis
  • Year Founded: 2016
  • HQ Location: New York, US
  • LinkedIn® Page: www.linkedin.com
    37 employees on LinkedIn®

Medlabreport

MedLabReport is an AI-powered service designed to help individuals interpret their medical exam results quickly and accurately. By uploading a single file, users receive a comprehensive, personalized report via email within five minutes. This report analyzes various diagnostic procedures, including blood tests, biopsies, imaging studies, and urine tests, providing clear insights tailored to the user's health concerns. The service leverages OpenAI's GPT-4 model, which surpasses the United States Medical Licensing Examination (USMLE) passing score by over 20 points, ensuring a high level of analytical proficiency. Key Features and Functionality: - Comprehensive Analysis: Processes a wide range of medical exam results, such as blood tests, biopsies, imaging studies, and urine tests, delivering a thorough overview of the user's health status. - Personalized Reports: Considers individual factors like symptoms and age to generate reports that focus on specific health concerns, enhancing relevance and clarity. - Rapid Turnaround: Delivers detailed reports within five minutes of file upload, enabling prompt understanding of medical results. - User-Friendly Format: Presents information in an easy-to-understand manner, empowering users to take control of their health decisions. Primary Value and Problem Solved: MedLabReport addresses the common challenge of interpreting complex medical exam results by providing clear, personalized insights swiftly. This service acts as a valuable second opinion, potentially identifying issues that might be overlooked, thereby enhancing the user's understanding of their health and facilitating informed discussions with healthcare providers. While it offers significant support, MedLabReport emphasizes that its reports are not a substitute for professional medical advice, diagnosis, or treatment.

Who Is the Company Behind Medlabreport?

Emma Stein
ES
Researched and written by Emma Stein
Updated October 21, 2026